ID   GLD2_HUMAN              Reviewed;         484 AA.
AC   Q6PIY7; Q86WZ2; Q8N927;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   15-MAR-2017, entry version 99.
DE   RecName: Full=Poly(A) RNA polymerase GLD2;
DE            Short=hGLD-2;
DE            EC=2.7.7.19;
DE   AltName: Full=PAP-associated domain-containing protein 4;
DE   AltName: Full=Terminal uridylyltransferase 2;
DE            Short=TUTase 2;
GN   Name=PAPD4; Synonyms=GLD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Smooth muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   ENZYME ACTIVITY.
RX   PubMed=15070731; DOI=10.1073/pnas.0400779101;
RA   Kwak J.E., Wang L., Ballantyne S., Kimble J., Wickens M.;
RT   "Mammalian GLD-2 homologs are poly(A) polymerases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:4407-4412(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=15987818; DOI=10.1261/rna.2630205;
RA   Rouhana L., Wang L., Buter N., Kwak J.E., Schiltz C.A., Gonzalez T.,
RA   Kelley A.E., Landry C.F., Wickens M.;
RT   "Vertebrate GLD2 poly(A) polymerases in the germline and the brain.";
RL   RNA 11:1117-1130(2005).
RN   [6]
RP   ABSENCE OF FUNCTION IN HISTONE MRNA DEGRADATION ACTIVITY.
RX   PubMed=18172165; DOI=10.1101/gad.1622708;
RA   Mullen T.E., Marzluff W.F.;
RT   "Degradation of histone mRNA requires oligouridylation followed by
RT   decapping and simultaneous degradation of the mRNA both 5' to 3' and
RT   3' to 5'.";
RL   Genes Dev. 22:50-65(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-69, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Cytoplasmic poly(A) RNA polymerase that adds successive
CC       AMP monomers to the 3'-end of specific RNAs, forming a poly(A)
CC       tail. In contrast to the canonical nuclear poly(A) RNA polymerase,
CC       it only adds poly(A) to selected cytoplasmic mRNAs. Does not play
CC       a role in replication-dependent histone mRNA degradation.
CC   -!- CATALYTIC ACTIVITY: ATP + RNA(n) = diphosphate + RNA(n+1).
CC       {ECO:0000269|PubMed:15070731}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with CPEB1, CPEB2, CPSF1 and PABPC1.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q13137:CALCOCO2; NbExp=3; IntAct=EBI-2802204, EBI-739580;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-2802204, EBI-740322;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6PIY7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PIY7-2; Sequence=VSP_034324;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain. Within brain, it is
CC       expressed in cerebellum, hippocampus and medulla.
CC       {ECO:0000269|PubMed:15987818}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-B-like family. GLD2
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK095818; BAC04629.1; -; mRNA.
DR   EMBL; CH471084; EAW95837.1; -; Genomic_DNA.
DR   EMBL; BC026061; AAH26061.1; -; mRNA.
DR   EMBL; BC047581; AAH47581.1; -; mRNA.
DR   CCDS; CCDS4048.1; -. [Q6PIY7-1]
DR   CCDS; CCDS75266.1; -. [Q6PIY7-2]
DR   RefSeq; NP_001107865.1; NM_001114393.1. [Q6PIY7-1]
DR   RefSeq; NP_001107866.1; NM_001114394.1. [Q6PIY7-1]
DR   RefSeq; NP_001284673.1; NM_001297744.1. [Q6PIY7-2]
DR   RefSeq; NP_001284674.1; NM_001297745.1.
DR   RefSeq; NP_776158.2; NM_173797.3. [Q6PIY7-1]
DR   RefSeq; XP_016864642.1; XM_017009153.1. [Q6PIY7-1]
DR   RefSeq; XP_016864643.1; XM_017009154.1. [Q6PIY7-1]
DR   RefSeq; XP_016864644.1; XM_017009155.1. [Q6PIY7-1]
DR   RefSeq; XP_016864645.1; XM_017009156.1. [Q6PIY7-1]
DR   RefSeq; XP_016864646.1; XM_017009157.1. [Q6PIY7-2]
DR   RefSeq; XP_016864647.1; XM_017009158.1. [Q6PIY7-2]
DR   RefSeq; XP_016864648.1; XM_017009159.1. [Q6PIY7-2]
DR   RefSeq; XP_016864649.1; XM_017009160.1. [Q6PIY7-2]
DR   UniGene; Hs.418198; -.
DR   ProteinModelPortal; Q6PIY7; -.
DR   BioGrid; 127943; 6.
DR   IntAct; Q6PIY7; 7.
DR   STRING; 9606.ENSP00000296783; -.
DR   iPTMnet; Q6PIY7; -.
DR   PhosphoSitePlus; Q6PIY7; -.
DR   BioMuta; PAPD4; -.
DR   DMDM; 74737798; -.
DR   EPD; Q6PIY7; -.
DR   MaxQB; Q6PIY7; -.
DR   PaxDb; Q6PIY7; -.
DR   PeptideAtlas; Q6PIY7; -.
DR   PRIDE; Q6PIY7; -.
DR   Ensembl; ENST00000296783; ENSP00000296783; ENSG00000164329. [Q6PIY7-1]
DR   Ensembl; ENST00000423041; ENSP00000393412; ENSG00000164329. [Q6PIY7-2]
DR   Ensembl; ENST00000428308; ENSP00000396861; ENSG00000164329. [Q6PIY7-1]
DR   Ensembl; ENST00000453514; ENSP00000397563; ENSG00000164329. [Q6PIY7-1]
DR   GeneID; 167153; -.
DR   KEGG; hsa:167153; -.
DR   UCSC; uc003kga.3; human. [Q6PIY7-1]
DR   CTD; 167153; -.
DR   GeneCards; PAPD4; -.
DR   HGNC; HGNC:26776; PAPD4.
DR   HPA; HPA054468; -.
DR   MIM; 614121; gene.
DR   neXtProt; NX_Q6PIY7; -.
DR   OpenTargets; ENSG00000164329; -.
DR   PharmGKB; PA134918975; -.
DR   eggNOG; KOG2277; Eukaryota.
DR   eggNOG; COG5260; LUCA.
DR   GeneTree; ENSGT00550000074490; -.
DR   HOGENOM; HOG000088606; -.
DR   HOVERGEN; HBG097533; -.
DR   InParanoid; Q6PIY7; -.
DR   KO; K14079; -.
DR   OMA; HHEINDA; -.
DR   OrthoDB; EOG091G0BUD; -.
DR   PhylomeDB; Q6PIY7; -.
DR   TreeFam; TF315661; -.
DR   BRENDA; 2.7.7.19; 2681.
DR   ChiTaRS; PAPD4; human.
DR   GenomeRNAi; 167153; -.
DR   PRO; PR:Q6PIY7; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164329; -.
DR   CleanEx; HS_PAPD4; -.
DR   ExpressionAtlas; Q6PIY7; baseline and differential.
DR   Genevisible; Q6PIY7; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0031380; C:nuclear RNA-directed RNA polymerase complex; IC:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:1990603; P:dark adaptation; IEA:Ensembl.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0043631; P:RNA polyadenylation; IDA:UniProtKB.
DR   InterPro; IPR002058; PAP_assoc.
DR   Pfam; PF03828; PAP_assoc; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Magnesium; Manganese; Metal-binding; mRNA processing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transferase.
FT   CHAIN         1    484       Poly(A) RNA polymerase GLD2.
FT                                /FTId=PRO_0000341549.
FT   DOMAIN      386    440       PAP-associated.
FT   MOTIF        76     92       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   METAL       213    213       Magnesium or manganese; catalytic.
FT                                {ECO:0000250}.
FT   METAL       215    215       Magnesium or manganese; catalytic.
FT                                {ECO:0000250}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      69     69       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     225    228       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034324.
FT   CONFLICT      9      9       R -> H (in Ref. 1; BAC04629).
FT                                {ECO:0000305}.
SQ   SEQUENCE   484 AA;  56028 MW;  26167D53ABDA979D CRC64;
     MFPNSILGRP PFTPNHQQHN NFFTLSPTVY SHQQLIDAQF NFQNADLSRA VSLQQLTYGN
     VSPIQTSASP LFRGRKRLSD EKNLPLDGKR QRFHSPHQEP TVVNQIVPLS GERRYSMPPL
     FHTHYVPDIV RCVPPFREIA FLEPREITLP EAKDKLSQQI LELFETCQQQ ISDLKKKELC
     RTQLQREIQL LFPQSRLFLV GSSLNGFGTR SSDGDLCLVV KEEPCFFQVN QKTEARHILT
     LVHKHFCTRL SGYIERPQLI RAKVPIVKFR DKVSCVEFDL NVNNIVGIRN TFLLRTYAYL
     ENRVRPLVLV IKKWASHHQI NDASRGTLSS YSLVLMVLHY LQTLPEPILP SLQKIYPESF
     SPAIQLHLVH QAPCNVPPYL SKNESNLGDL LLGFLKYYAT EFDWNSQMIS VREAKAIPRP
     DGIEWRNKYI CVEEPFDGTN TARAVHEKQK FDMIKDQFLK SWHRLKNKRD LNSILPVRAA
     VLKR
//
